STAA Insider Trading
STAAR SURGICAL CO | Ophthalmic Goods
Comprehensive Trading Performance Summary
The investment history of corporate insiders at STAAR SURGICAL CO provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Ophthalmic Goods sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2013-08-20 02:49 | 2013-08-05 | ANDREWS DEBORAH J | Officer, Other - Vice President | OPT+S | $11.79 | 11,721 | $138,178 | 36,400 | 0.0% |
| 2013-08-15 23:35 | 2013-08-09 | ANDREWS DEBORAH J | Officer, Other - Vice President | SELL | $11.63 | 3,928 | $45,678 | 22,621 | -14.8% |
| 2013-08-13 00:54 | 2013-08-08 | ANDREWS DEBORAH J | Officer, Other - Vice President | SELL | $11.62 | 9,079 | $105,530 | 22,621 | -28.6% |
| 2013-08-08 00:01 | 2013-08-05 | ANDREWS DEBORAH J | Officer, Other - Vice President | SELL | $11.79 | 11,721 | $138,178 | 24,639 | -32.2% |
| 2013-05-10 03:56 | 2013-05-09 | ANDREWS DEBORAH J | Officer, Other - Vice President | SELL | $8.96 | 5,000 | $44,819 | 36,400 | -12.1% |
| 2012-12-12 00:35 | 2012-12-11 | Moore John C | Director | BUY | $5.46 | 5,000 | $27,300 | 45,000 | +12.5% |
| 2012-11-20 02:03 | 2012-11-15 | BROADWOOD PARTNERS LP | 10% owner | BUY | $5.00 | 2,618 | $13,090 | 6,401,639 | +0.0% |
| 2012-11-17 00:49 | 2012-11-08 | LOGAN MARK B | Director | BUY | $5.22 | 3,600 | $18,808 | 19,600 | +22.5% |
| 2012-11-14 20:08 | 2012-11-14 | Caldwell Barry G | Director, Officer - President and CEO | BUY | $5.04 | 5,000 | $25,200 | 251,839 | +2.0% |
| 2012-11-07 03:15 | 2012-11-02 | BROADWOOD PARTNERS LP | 10% owner | BUY | $5.00 | 22,572 | $112,853 | 6,399,021 | +0.4% |
| 2012-08-23 01:36 | 2012-08-20 | GOODMEN WILLIAM WALTER | Officer - Global VP, Human Resources | OPT+S | $6.97 | 16,667 | $116,217 | 15,000 | 0.0% |
| 2012-08-14 01:49 | 2012-08-09 | Caldwell Barry G | Director, Officer - President and CEO | BUY | $6.57 | 5,000 | $32,827 | 246,839 | +2.1% |
| 2012-08-03 01:29 | 2012-07-31 | BROADWOOD PARTNERS LP | 10% owner | BUY | $5.14 | 296,718 | $1,524,181 | 6,376,449 | +4.9% |
| 2012-06-07 20:57 | 2012-06-05 | Felberg Craig | Officer - VP, R&D and Clinical Affairs | SELL | $8.25 | 15,000 | $123,750 | 8,700 | -63.3% |
| 2012-06-08 03:22 | 2012-06-07 | Todd Donald J | Officer - President, Asia/Pacific | SELL | $8.50 | 1,200 | $10,204 | 7,500 | -13.8% |
| 2012-06-05 20:22 | 2012-05-29 | Caldwell Barry G | Director, Officer - President and CEO | BUY | $8.86 | 5,000 | $44,281 | 241,839 | +2.1% |
| 2012-06-05 20:22 | 2012-05-31 | LOGAN MARK B | Director | BUY | $8.55 | 2,000 | $17,100 | 15,000 | +15.4% |
| 2012-06-05 20:21 | 2012-05-23 | LOGAN MARK B | Director | BUY | $8.75 | 3,000 | $26,250 | 16,000 | +23.1% |
| 2012-05-12 00:29 | 2012-05-11 | GOODMEN WILLIAM WALTER | Officer - Global VP, Human Resources | SELL | $10.44 | 600 | $6,264 | 15,000 | -3.8% |
| 2012-05-10 01:20 | 2012-05-09 | GOODMEN WILLIAM WALTER | Officer - Global VP, Human Resources | OPT+S | $10.29 | 6,666 | $68,621 | 15,600 | 0.0% |
| 2012-03-07 02:53 | 2012-03-02 | Felberg Craig | Officer - VP, R&D and Clinical Affairs | SELL | $148.52 | 800 | $118,818 | 23,700 | -3.3% |
| 2012-03-07 02:55 | 2012-03-02 | Hughes Robin | Officer - Vice President, Marketing | SELL | $11.02 | 2,000 | $22,042 | 56,000 | -3.4% |
| 2012-03-07 02:52 | 2012-03-02 | Todd Donald J | Officer - President, Asia/Pacific | SELL | $11.04 | 800 | $8,835 | 8,700 | -8.4% |
| 2012-03-07 02:54 | 2012-03-02 | GOODMEN WILLIAM WALTER | Officer - Global VP, Human Resources | OPT+S | $11.03 | 300 | $3,310 | 8,100 | 0.0% |
| 2012-03-07 02:53 | 2012-03-02 | FAGEN DONALD L | Officer - V.P. Sales for N. America | SELL | $11.02 | 1,200 | $13,224 | 9,300 | -11.4% |
| 2011-12-03 00:13 | 2011-12-01 | MORRISON DAVID R | Director | SELL | $9.80 | 20,000 | $196,000 | 40,000 | -33.3% |
| 2011-11-19 01:27 | 2011-11-16 | Todd Donald J | Officer - President, Asia/Pacific | OPT+S | $9.00 | 5,000 | $45,000 | 9,500 | 0.0% |
| 2011-11-04 01:02 | 2011-11-02 | Hughes Robin | Officer - Vice President, Marketing | SELL | $9.12 | 20,000 | $182,492 | 58,000 | -25.6% |
| 2011-11-03 02:47 | 2011-10-31 | DUFFY DONALD | Director | SELL | $9.15 | 4,000 | $36,608 | 54,000 | -6.9% |
| 2011-09-09 23:31 | 2011-09-07 | MORRISON DAVID R | Director | SELL | $8.03 | 13,846 | $111,114 | 60,000 | -18.7% |
| 2011-09-01 04:24 | 2011-08-29 | DUFFY DONALD | Director | OPT+S | $8.30 | 37,000 | $307,222 | 58,000 | 0.0% |
| 2011-08-30 03:34 | 2011-08-25 | FAGEN DONALD L | Officer - V.P. Sales for N. America | OPT+S | $7.44 | 16,666 | $124,055 | 10,500 | 0.0% |
| 2011-08-27 02:35 | 2011-08-26 | Caldwell Barry G | Director, Officer - President and CEO | SELL | $8.05 | 10,000 | $80,500 | 221,839 | -4.3% |
| 2011-08-27 02:36 | 2011-08-26 | Kaufman Charles S | Officer - V.P. , General Counsel | SELL | $8.19 | 2,000 | $16,385 | 33,500 | -5.6% |
| 2011-08-20 03:33 | 2011-08-18 | ANDREWS DEBORAH J | Officer - VP & Chief Financial Officer | SELL | $6.59 | 30,000 | $197,562 | 23,400 | -56.2% |
| 2011-08-20 03:34 | 2011-08-18 | GOODMEN WILLIAM WALTER | Officer - Global VP, Human Resources | OPT+S | $6.71 | 16,666 | $111,862 | 8,500 | 0.0% |
| 2011-08-06 02:14 | 2011-08-05 | BAILEY DON M | Director | BUY | $5.53 | 50,802 | $280,747 | 145,139 | +53.9% |
| 2011-06-14 03:02 | 2011-06-09 | Kaufman Charles S | Officer - V.P. , General Counsel | SELL | $5.24 | 3,000 | $15,707 | 125,500 | -2.3% |
| 2011-05-12 01:29 | 2011-05-09 | Moore John C | Director | BUY | $5.43 | 5,000 | $27,142 | 10,000 | +100.0% |
| 2011-04-22 20:36 | 2011-04-20 | BROADWOOD PARTNERS LP | 10% owner | BUY | $4.54 | 22,500 | $102,148 | 6,079,731 | +0.4% |
| 2011-03-09 05:00 | 2011-03-07 | Felberg Craig | Officer - VP, R&D and Clinical Affairs | SELL | $5.74 | 2,000 | $11,489 | 77,000 | -2.5% |
| 2011-03-09 05:00 | 2011-03-07 | Hughes Robin | Officer - Vice President, Marketing | SELL | $5.75 | 2,000 | $11,490 | 138,000 | -1.4% |
| 2010-12-13 23:23 | 2010-12-06 | Kamijo Isamu | Officer - President, STAAR Japan Inc. | OPT+S | $5.52 | 16,666 | $91,996 | 23,334 | 0.0% |
| 2010-09-11 01:05 | 2010-09-08 | BROADWOOD PARTNERS LP | 10% owner | BUY | $4.37 | 28,593 | $124,949 | 6,057,231 | +0.5% |
| 2009-12-09 02:49 | 2009-12-08 | MEIER RICHARD A | Director | BUY | $2.94 | 5,000 | $14,701 | 25,000 | +25.0% |
| 2009-09-15 04:49 | 2009-09-10 | Moore John C | Director | BUY | $4.09 | 3,000 | $12,270 | 5,000 | +150.0% |
| 2009-08-26 04:52 | 2009-08-21 | BAILEY DAVID | Director, Officer - President, Int'l Operations | SELL | $3.23 | 47,766 | $154,098 | 1,127,800 | -4.1% |
| 2009-08-14 03:44 | 2009-08-13 | MEIER RICHARD A | Director | BUY | $3.15 | 10,000 | $31,462 | 20,000 | +100.0% |
| 2009-08-11 04:23 | 2009-08-10 | MEIER RICHARD A | Director | BUY | $2.75 | 10,000 | $27,500 | 10,000 | +100.0% |
| 2009-06-18 17:29 | 2009-06-16 | BROADWOOD PARTNERS LP | 10% owner | BUY | $1.88 | 1,159,362 | $2,179,601 | 6,028,638 | +23.8% |
How to Interpret $STAA Trades
Not every insider transaction in STAAR SURGICAL CO is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $STAA shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for STAA
Insider activity data for STAAR SURGICAL CO is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $STAA, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.